Cargando…

Up to your NEK2 in CIN

Detalles Bibliográficos
Autores principales:	Seachrist, Darcie D., Anstine, Lindsey J., Keri, Ruth A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057269/ https://www.ncbi.nlm.nih.gov/pubmed/33889296 http://dx.doi.org/10.18632/oncotarget.27918

Ejemplares similares

FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer
por: Seachrist, Darcie D., et al.
Publicado: (2021)

TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters
por: Webb, Bryan M., et al.
Publicado: (2021)

KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene
por: Roberts, Melyssa S., et al.
Publicado: (2020)

Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer
por: Seachrist, Darcie D., et al.
Publicado: (2017)

Predictive Testing of Early CIN Behaviour by Molecular Biomarkers
por: Baak, Jan P. A., et al.
Publicado: (2005)

The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer
por: Kao, Hung-Ying, et al.
Publicado: (2023)

Nek5: a new regulator of centrosome integrity
por: Prosser, Suzanna L., et al.
Publicado: (2015)

The Ed. Ef Cin. Med. Jour. Remarks
Publicado: (1889)

Kinase Inhibitor Profile for Human Nek1, Nek6, and Nek7 and Analysis of the Structural Basis for Inhibitor Specificity
por: Moraes, Eduardo Cruz, et al.
Publicado: (2015)

HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions
por: Mariani, Luciano, et al.
Publicado: (2016)

The wages of CIN
por: Yuen, Karen W., et al.
Publicado: (2008)

Iso-osmolar Iodixanol Is Better than Low-osmolar Contrast for CIN Prevention. And Then?
por: Jo, Sang-Ho
Publicado: (2021)

Therapeutic vaccination using HPV 16 E7 to eradicate CIN3
por: Tewari, Krishnansu S.
Publicado: (2019)

Disruption of CDK7 signaling leads to catastrophic chromosomal instability coupled with a loss of condensin-mediated chromatin compaction
por: Piemonte, Katrina M., et al.
Publicado: (2023)

Mechanistic basis of Nek7 activation through Nek9 binding and induced dimerization
por: Haq, Tamanna, et al.
Publicado: (2015)

Open Up your Science in EHJ Open
por: Bäck, Magnus, et al.
Publicado: (2021)

Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort
por: Bonde, Jesper, et al.
Publicado: (2019)

Characterization of the Human NEK7 Interactome Suggests Catalytic and Regulatory Properties Distinct from Those of NEK6
por: de Souza, Edmarcia Elisa, et al.
Publicado: (2014)

New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing
por: Basei, Fernanda Luisa, et al.
Publicado: (2015)

Mitotic Regulation by NEK Kinase Networks
por: Fry, Andrew M., et al.
Publicado: (2017)

Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor Development
por: Dana, Dibyendu, et al.
Publicado: (2022)

An Autoinhibitory Tyrosine Motif in the Cell-Cycle-Regulated Nek7 Kinase Is Released through Binding of Nek9
por: Richards, Mark W., et al.
Publicado: (2009)

Tincture Cin Honœ Ferrata
por: Sims, Samuel
Publicado: (1853)

HPV Tests Comparison in the Detection and Follow-Up after Surgical Treatment of CIN2+ Lesions
por: Bottari, Fabio, et al.
Publicado: (2022)

Progression of CIN1/LSIL HPV Persistent of the Cervix: Actual Progression or CIN3 Coexistence
por: Bruno, Maria Teresa, et al.
Publicado: (2021)

The team briefing: setting up relational coordination for your resuscitation
por: Purdy, Eve, et al.
Publicado: (2020)

HPV DNA testing improves CIN2+ risk stratification and detection of CIN2+ in delayed triage of ASCUS and LSIL. A population-based follow-up study from Western Norway
por: Budal, Elisabeth B, et al.
Publicado: (2014)

LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression
por: Montañez-Wiscovich, ME, et al.
Publicado: (2009)

Inhibition of Nek2 by Small Molecules Affects Proteasome Activity
por: Meng, Lingyao, et al.
Publicado: (2014)

Cherish Your Exceptions, But Also Your Doubts
por: de Grey, Aubrey D.N.J.
Publicado: (2019)

Centrosomal kinase Nek2 cooperates with oncogenic pathways to promote metastasis
por: Das, T K, et al.
Publicado: (2013)

Power up your clssroom : reimagine learning through gameplay /
por: Blass, Lindsey

Quantitative Histopathological Analysis of CIN Sections
por: Baak, Jan P. A.
Publicado: (2006)

Evaluating HPV‐negative CIN2+ in the ATHENA trial
por: Petry, Karl Ulrich, et al.
Publicado: (2016)

Underdiagnosis of cervical intraepithelial neoplasia (CIN) 2 or Worse Lesion in Women with a Previous Colposcopy-Guided Biopsy Showing CIN 1
por: Souza, Carlos André Scheler de, et al.
Publicado: (2017)

A new assay for measuring chromosome instability (CIN) and identification of drugs that elevate CIN in cancer cells
por: Lee, Hee-Sheung, et al.
Publicado: (2013)

Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?
por: Austin, R. Marshall, et al.
Publicado: (2020)

Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines
por: Demarco, Maria, et al.
Publicado: (2017)

Insights into the Conformational Variability and Regulation of Human Nek2 Kinase
por: Westwood, Isaac, et al.
Publicado: (2009)

NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_587fuah4aep97mn2su4h93t2qh